Drug Induced Sleep Endoscopy Identification of Adenoid Regrowth in Pediatric Obstructive Sleep Apnea

Table 1

Demographics and clinical characteristics of pediatric OSA patients undergoing DISE after previous adenoidectomy.

Variable		%
Gender
Male	35	62.5
Female	21	37.5
Age (mean ± 95% CI, years)
Initial adenoidectomy	5.36 ± 0.91	-
First DISE	7.11 ± 0.93	-
Timeframe (mean ± 95% CI, years)
Time between initial adenoidectomy and DISE	1.75 ± 0.39	-
Time between adenoidectomies	2.37 ± 0.45	-
Mean AHI (mean ± 95% CI, events/hour)
Pre-DISE	8.53 ± 4.5
Improvement after DISE-related surgery	−6.33 ± 5.9
BMI for age percentile at first DISE
Group 1 underweight (<25%)	7	12.5
Group 2 normal weight (25% to <85%)	18	32.1
Group 3 overweight (85% to <95%)	5	8.9
Group 4 obese (95%+)	26	46.4
Comorbid conditions at time of first DISE
Allergic rhinitis	26	46.4
Asthma	20	35.7
Developmental	16	28.6
Reflux	18	32.1
Behavioral disorders	18	32.1
Hypertension	5	8.9
Laryngomalacia	6	10.7
Follow-up sleep surgery after DISE	48	85.7

OSA, obstructive sleep apnea; DISE, drug induced sleep endoscopy; CI, confidence interval; AHI, apnea-hypopnea index; BMI, body mass index. to autism, hypotonia, muscular dystrophy, trisomy 21, trisomy 12, fragile X, and etiology unknown.